Skip to content
Recall Observatory FDA recall evidence

Drug product

Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120. NDC: 29033-056-01

D-0249-2021

January 25, 2021

Class II

Product summary

Firm
Nostrum Laboratories Inc
Event
Event 87210
Status
Ongoing
Classification
Class II
Quantity
7071 bottles
Official record key
drug-enforcement:D-0249-2021

Official wording

Reason: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.

Code information: Lot MET200601, 07/2022

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    NDMA) impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations